0
Skip to Content
Health Business Group
Services ▾
Growth Strategy
Due Diligence for Transactions
Sectors ▾
Tech-enabled Healthcare Services
Life Sciences
Digital Health and Health IT
Private Equity/Investors
About ▾
Consultants
Case Studies
History
Testimonials
Media Room
blog
Contact
Health Business Group
Services ▾
Growth Strategy
Due Diligence for Transactions
Sectors ▾
Tech-enabled Healthcare Services
Life Sciences
Digital Health and Health IT
Private Equity/Investors
About ▾
Consultants
Case Studies
History
Testimonials
Media Room
blog
Contact
Folder: Services ▾
Back
Growth Strategy
Due Diligence for Transactions
Folder: Sectors ▾
Back
Tech-enabled Healthcare Services
Life Sciences
Digital Health and Health IT
Private Equity/Investors
Folder: About ▾
Back
Consultants
Case Studies
History
Testimonials
Media Room
blog
Contact
Economics, International, Pharma 3/20/09 Economics, International, Pharma 3/20/09

The last lever for big pharma?

Read More
Announcements, Pharma 3/19/09 Announcements, Pharma 3/19/09

How low can they go?

Read More
Amusements, Pharma 3/18/09 Amusements, Pharma 3/18/09

Here's how you can tell that times are tough

Read More
Pharma, Policy and politics 3/12/09 Pharma, Policy and politics 3/12/09

The folly of biogenerics

Read More
Devices, Economics, Pharma, Physicians 2/10/09 Devices, Economics, Pharma, Physicians 2/10/09

Pharma disclosure or medical profession disclosure?

Read More
Amusements, Pharma, Policy and politics 1/28/09 Amusements, Pharma, Policy and politics 1/28/09

The name should have been enough of a warning

Read More
Pharma, Physicians 1/12/09 Pharma, Physicians 1/12/09

How to win friends and influence people

Read More
Pharma, Policy and politics 1/8/09 Pharma, Policy and politics 1/8/09

FDA staff: Damned if they do and if they don't

Read More
Pharma, Policy and politics 1/8/09 Pharma, Policy and politics 1/8/09

FDA staff: Damned if they do and if they don't

Read More
Pharma 1/6/09 Pharma 1/6/09

In the eye of the beholder

Read More
Economics, Pharma, Policy and politics 12/30/08 Economics, Pharma, Policy and politics 12/30/08

A me-too strategy for me-too drugs

Read More
International, Pharma 12/18/08 International, Pharma 12/18/08

Eyes on the prize

Read More
Pharma, Policy and politics, Research 12/12/08 Pharma, Policy and politics, Research 12/12/08

Asthma drug dangers: Hiding in plain sight

Read More
Economics, Pharma, Policy and politics 12/10/08 Economics, Pharma, Policy and politics 12/10/08

Generic biologics --or Me Too Drugs 2.0?

Read More
Economics, Pharma 12/4/08 Economics, Pharma 12/4/08

Time for some hotel name changes?

Read More
Pharma, Policy and politics 11/14/08 Pharma, Policy and politics 11/14/08

Is big pharma preparing to shoot itself in the foot?

Read More
e-health, Economics, Entrepreneurs, Pharma 10/27/08 e-health, Economics, Entrepreneurs, Pharma 10/27/08

Podcast interview with Ralph Kalies, CEO of BidRx (transcript)

Read More
Amusements, Pharma 10/24/08 Amusements, Pharma 10/24/08

Pharmacy benefit brainstorm: Ultragenerics

Read More
Pharma, Physicians, Policy and politics 10/23/08 Pharma, Physicians, Policy and politics 10/23/08

Pharma and physicians: It takes two to tango

Read More
Pharma, Policy and politics 9/29/08 Pharma, Policy and politics 9/29/08

Bye bye to Boston's Canadian drug importation program

Read More
Newer Posts
Older Posts

SERVICES

Growth StrategyDue Diligence for Transactions

SECTORS

Tech-enabled Healthcare Services
Life Sciences

Digital Health and Health IT
Private Equity/Investors

ABOUT

Consultants
Case Studies
History
Testimonials

Media Room
Blog
Contact

101 Federal St., S. 1900 | Boston, MA 02110 | (617) 731-3182

© 2024 Health Business Group. All Rights Reserved.